Erasca, Inc. (ERAS) earnings date
Mar 18, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 27% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 43 days, typically, give or take 15 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Thu, Nov 12, 2026 | after close | 43 | 8-K |
| Q2 FY2026 | Tue, Aug 11, 2026 | after close | 42 | 8-K |
| Q1 FY2026 | Mon, May 11, 2026 | after close | 41 | 8-K |
| Q4 FY2025 | Thu, Mar 12, 2026 | after close | 71 | 8-K |
| Q3 FY2025 | Wed, Nov 12, 2025 | after close | 43 | 8-K |
| Q2 FY2025 | Tue, Aug 12, 2025 | after close | 43 | 8-K |
| Q1 FY2025 | Tue, May 13, 2025 | after close | 43 | 8-K |
| Q4 FY2024 | Thu, Mar 20, 2025 | after close | 79 | 8-K |
What they guided beta
| Q3 FY2026 | "Erasca Reports Third Quarter 2026 Business Updates and Financial Results ERAS-0015 granted FDA Fast Track Designation for metastatic pancreatic adenocarcinoma; advancing toward three potentially registration-enabling trials in pancreatic and lung cancers Updated ERAS-0015 monotherapy and nonclinical ERAS-0015/ERAS-4001 combination data to be presented at ENA; expect preliminary ERAS-4001 data in H2 2026 and ERAS-0015 data in H1 2027 Cash, cash equivalents, and marketable securities of $948 million as of September 30, 2026 SAN DIEGO, November 12, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: " exhibit |
| Q3 FY2026 | "Phase 1 monotherapy expansion data expected in the first half of 2027" exhibit |
| Q3 FY2026 | "Phase 1 combination dose escalation data, including panitumumab combination, expected in the first half of 2027" exhibit |
| Q3 FY2026 | "Potentially registration-enabling trial in second line or greater NSCLC expected to initiate in the first half of 2027" exhibit |
| Q3 FY2026 | "Phase 3 pivotal trial in first line PDAC expected to initiate in 2027" exhibit |
| Q2 FY2026 | "Erasca Reports Second Quarter 2026 Business Updates and Financial Results Updated ERAS-0015 data in U.S. trial highlighted compelling monotherapy efficacy in 2L+ KRAS G12X PDAC and continued favorable tolerability, as well as further advancement of panitumumab CRC combination ERAS-0015 program advancing toward three potentially registration-enabling trials in pancreatic and lung cancers Additional ERAS-0015 monotherapy and combination data expected in H1 2027; ERAS-4001 Phase 1 preliminary monotherapy data expected in H2 2026 Cash, cash equivalents, and marketable securities of $384 million a" exhibit |
| Q2 FY2026 | "Phase 1 monotherapy expansion data expected in the first half of 2027" exhibit |
| Q2 FY2026 | "Phase 1 combination dose escalation data, including panitumumab combination, expected in the first half of 2027" exhibit |
| Q2 FY2026 | "Potentially registration-enabling trial in 2L+ NSCLC expected to initiate in the first half of 2027" exhibit |
| Q2 FY2026 | "Phase 3 pivotal trial in 1L PDAC expected to initiate in 2027" exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/ERAS
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/ERAS
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/ERAS/"><img src="https://veritasdata.dev/embed/ERAS.svg" alt="ERAS earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/ERAS/)
Script
<script async src="https://veritasdata.dev/embed/ERAS.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/ERAS"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.